ALDX Earnings

Quarterly EPS
$-0.25
Q3 2024
$-0.27
Q4 2024
$-0.17
Q1 2025
$-0.16
Q2 2025
$-0.13
Q3 2025
$-0.11
Q4 2025
$-0.06
Q1 2026
$-0.09
Q2 2026
Latest RevenueN/A
Latest Net Income-5450273
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.090-5450273+43.8%
Q1 2026-$0.060-3452619+64.7%
Q4 2025-$0.110-6461507+59.3%
Q3 2025-$0.130-7688341+48.0%
Q2 2025-$0.160-9767312+42.9%
Q1 2025-$0.170-9929501-21.4%
Q4 2024-$0.270-15808767-237.5%
Q3 2024-$0.250-15112983-78.6%
Q2 2024-$0.280-16847572
Q1 2024-$0.140-8082122
Q4 2023-$0.080-4752962
Q3 2023-$0.140-8186871
Aldeyra Therapeutics (ALDX) — Earnings